Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma. [electronic resource]
Producer: 20131022Description: 499-506 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carboplatin -- administration & dosage
- Cisplatin -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Drug Resistance, Neoplasm -- drug effects
- Etoposide -- administration & dosage
- Female
- Humans
- Ifosfamide -- administration & dosage
- Immunotherapy -- methods
- Lymphoma, B-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm Grading
- Recurrence
- Survival Analysis
- Treatment Failure
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.